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It is generally accepted that inhibition of nitric oxide synthase
(NOS) facilitates, and thus nitric oxide (NO) inhibits, contractility of
skeletal muscle. However, standard assessments of contractility
are carried out at a nonphysiological oxygen tension [partial
pressure of oxygen (pO2)] that can interfere with NO signaling
(95% O2). We therefore examined, in normal and neuronal NOS
(nNOS)-deficient mice, the influence of pO2 on whole-muscle
contractility and on myocyte calcium flux and sarcomere shorten-
ing. Here, we demonstrate a significant enhancement of these
measures of muscle performance at low physiological pO2 and an
inhibitory influence at higher physiological pO2, which depend on
endogenous nNOS. At 95% O2 (which produces oxidative stress;
muscle core pO2 400 mmHg), force production is enhanced but
control of contractility by NOnitrosylation is greatly attenuated.
In addition, responsivity to pO2 is altered significantly in nNOS
mutant muscle. These results reveal a fundamental role for the
concerted action of NO and O2 in physiological regulation of
skeletal muscle contractility, and suggest novel molecular aspects
of myopathic disease. They suggest further that the role of NO in
some cellular systems may require reexamination.
I t has recently been recognized that redox-based regulation ofprotein function serves not only to mediate compensatory
responses to oxidative or nitrosative stress but also modulates
transduction along basic signaling pathways in mammalian cells
(1). Further, accumulating evidence indicates that nitric oxide
(NO)-based protein modifications are critical effectors of redox
regulation, which may be linked at the molecular level to partial
pressure of oxygen (pO2) (1). Accordingly, the functional con-
tribution of redox mechanisms remains, for the most part,
untested, and potentially masked in virtually all ex vivo studies,
which have been carried out at supranormal oxygen tension
(typically 21% O2 for cells and 95% O2 for tissue, whereas pO2
in vivo is much lower).
Mammalian skeletal muscle operates over a range of pO2,
which is determined by local blood flow and muscle activity, and
contains endogenous sources of NO. The -isoform of type I or
neuronal NO synthase (nNOS) localizes to the plasma mem-
brane (sarcolemma) of skeletal muscle fibers through interaction
with the dystrophin complex (2–4). In many mammals, nNOS is
either restricted to or particularly abundant in fast-twitch fibers,
although, in humans, fast- and slow-twitch fibers are more evenly
endowed (2, 5, 6). The loss of nNOS from sarcolemma of mdx
mice (whose fast-twitch fibers are disproportionately impaired),
and of patients with Duchenne or Becker muscular dystrophy,
focused interest on the possibility that NO produced by muscle
fibers may play a role in excitation–contraction (E–C) coupling
and that NO deficiency may contribute to contractile impair-
ment in muscle disease (2–6). However, although mice deficient
in nNOS show subtle abnormalities in muscle blood flow (7),
overt alterations in contractile function have not been described.
Studies of isolated skeletal muscle have generally been carried
out at grossly nonphysiological oxygen tension, usually 95% O2,
whereas skeletal muscle pO2 is in the range from 4 to 20 mmHg
(0.5–2.5% O2), and even lower in working muscle (8, 9). Su-
pranormal O2 concentrations have been shown in vitro to disrupt
regulation by NO of the ryanodine receptorcalcium release
channel (RyR1) of skeletal muscle sarcoplasmic reticulum (SR)
(10). Therefore, to reveal the physiological role of O2NO in
regulation of muscle function, we examined, over a range of pO2,
the contractile properties and calcium fluxsarcomere shorten-
ing, respectively, of isolated predominantly fast-twitch whole-
muscle [extensor digitorum longus (EDL)] and single myocytes
[f lexor digitorum brevis (FDB)] obtained from normal and from
genetic knockout mice in which nNOS is selectively absent
(nNOS) (11).
Experimental Procedures
Muscle Bioassay. EDL muscles were obtained from male mice at
6–8 weeks of age (nNOSand C57BL6, The Jackson Labo-
ratory). Each experiment used the left and right EDL from a
single mouse, which were removed and suspended from proximal
and distal tendons, in series with force transducers, in organ
baths at 37°C containing Krebs’ solution supplemented with
D-tubocurarine (25 M; to eliminate any influence of neuro-
muscular transmission). Muscles were allowed to equilibrate
for 15 min at 5% CO2 and either 1–2% O2, 20% O2, or 95%
O2. Bath oxygen tension was monitored with an oxygen electrode
(WPI Instruments, Waltham, MA). When used, L-nitroarginine
methyl ester (L-NAME) (1 mM) was added to the bath at the
beginning of the equilibration period. All measurements of
muscle pairs were carried out in parallel. Contractions were
elicited by square-wave constant-voltage stimulation (50–80 V)
of 2 msec duration through 7.0-mm-wide platinum electrodes
placed parallel to the long axis of the muscle. Before testing, each
muscle was adjusted to the length at which isometric twitch-force
generation was maximal (optimum muscle length, Lo). At least
2 min elapsed between single-twitch stimuli, and between trains
of tetanic stimuli, and tetanic testing always followed the com-
pletion of single-twitch measurements. Tetanic stimulation con-
sisted of pulse trains of 75 msec duration, and the amplitude of
individual stimuli was set at a level equal to either half-maximal
or maximal single-twitch stimulation. For each muscle, Lo was
measured after the final tetanic stimulation, the muscle was
weighed wet, and the effective cross-sectional area was calcu-
lated by approximating the muscle as a cylinder of length, Lo, and
a density of 1.06 gmcm3 (12). Because Lo did not differ
significantly between WT and nNOS/ EDL (1.35  0.06 cm vs.
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1.36  0.06 cm, P  0.77), differences in effective cross-sectional
area were largely a result of differences in muscle mass. Be-
tween-group analyses of single or multiple parameters were
carried out, respectively, with Student’s t test and ANOVA.
Measurement of Muscle pO2. EDL muscles were fixed horizontally
in Krebs’ solution bubbled continuously with 20% O25% CO2.
A polaragraphic oxygen electrode (glass micropipette; tip diam-
eter 10 m), calibrated after each use, was used to measure
pO2 after penetration of the muscle core (13). The composition
of the sparging gas was changed sequentially from 20% O2 to
95% O2 and 1% O2 after equilibration at each pO2 (10 min).
Myocyte Ca2 Transients and Sarcomere Shortening. FDB muscles
obtained from C57BL6 and nNOS/ mice were incubated with
2% collagenase type 2 (Worthington Lab) for 18 h at 37°C under
95%O25% CO2 before myocytes were dispersed and stored
until use in Tyrodes solution containing 1.8 mM Ca2 at room
temperature. For experimental observations, myocytes were
transferred to a sealed microscope stage compartment and
superfused continuously at room temperature with Tyrodes
solution containing 1.8 mM Ca2 and 0.5 mM probenecid.
Observations were obtained first at 20% O2 before adjustment
to 1% O2. Depolarizing stimulation (pacing) was delivered
continuously at 0.5 Hz. Measurement of intracellular Ca2 and
of sarcomere length were as described (14). Ca2 measurement
used Fura-2AM (5 M) and a dual-wavelength spectropho-
tometer exciting alternately at 365 and 380 nm. Sarcomere length
was monitored continuously with a charge-coupled device cam-
era and changes in sarcomere length were determined by fast
Fourier transform of the Z-line density trace.
Results
We first compared the contractile properties of EDL at a
physiologically extreme bath oxygen tension of 20–21% O2 (pO2
150 mmHg, ambient pO2), which represents an oxidative stress
for peripheral tissue, and at 1–2% O2 (pO2 10 mmHg), which
is characteristic of normal mammalian striated muscle in vivo (8,
9). Direct measurement at the muscle core (see Experimental
Procedures and Table 1) indicated that mean muscle pO2 was
40 mmHg (median 36.7 mmHg) at 20% bath O2 and 3.5
mmHg (median 1.75 mmHg) at 1–2% bath O2. Thus, 1–20%
bath O2 recapitulates the physiological O2 gradient in skeletal
muscle (8, 9). In addition, to allow a direct comparison with
previous results, we examined EDL performance at 95% bath O2
(pO2 700 mmHg), in which we measured a core pO2 400
mmHg, thus eliminating the physiological O2 gradient (Table 1).
Some measurements of muscle performance were obtained
sequentially at different oxygen tensions to examine the time
course and reversibility of pO2-dependent changes in contrac-
tility (see Fig. 2 A).
We assessed fundamental measures of E–C coupling and force
production, isometric and tetanic twitch tensions, for muscles
adjusted along their length-tension curve to optimize force
generation. Measurements of force evoked by single-pulse stim-
ulation revealed that, with stimuli producing about half-maximal
twitch tension, the force generated by EDL was increased by
45% at 1% vs. 20% O2, and even for stimuli producing maximal
twitch tensions, twitch tension amplitude was 20% greater at
low pO2 (P  0.05; Fig. 1A). These observations reveal pO2-
dependent regulation of E–C coupling, and recent findings
provide a likely mechanism: NO modifies by S-nitrosylation a
single cysteine residue (Cys-3635) within RyR1 and thereby
augments substantially Ca2 f lux through RyR1, which governs
active contraction (10, 15). Remarkably, NO acts on this critical
thiol only at physiological O2 concentrations (10 mmHg or
less), where the pO2-dependent redox state of a small subset of
RyR1 thiols (representing an O2 sensor) is reduced, thereby
producing an NO-responsive conformation in the channel (10).
In contrast, NO has no effect at supranormal pO2, where these
allosteric effector thiols are oxidized. Thus, mechanistic analysis
of NO effects on RyR1 indicates that NO should facilitate
contractility at low physiological pO2. In contrast, the original
analysis of diaphragm muscle (5, 16) and subsequent studies
(reviewed in ref. 6), all carried out at supraphysiological pO2,
have reported consistently that pharmacologic inhibition of NOS
enhances force production by skeletal muscle ex vivo (i.e., NO is
inhibitory).
We reassessed directly the role of endogenous NO in pO2-
dependent regulation of contractility employing both nNOS/
mice and acute inhibition of NOS with L-NAME. The isometric
twitch tensions developed by EDL from nNOS/ mice were
indistinguishable at 1% or 20% O2, with either submaximal or
maximal stimulation (Figs. 1B and 2B). Thus, in the absence of
endogenous NO production by nNOS, the influence of pO2 on
twitch tension is completely eliminated. This finding, in combi-
nation with the increase in twitch tension at low vs. high pO2 in
WT EDL (Fig. 1 A), indicates a concerted influence of pO2 and
NO that results in the enhancement by endogenous NO of E–C
coupling and force production at physiological oxygen tension.
In addition, we observed that nNOS/ EDL generated greater
twitch force than did WT EDL (normalized for cross-sectional
area), at both low and high pO2 (Fig. 1). At 1% O2, this increase
was nonsignificant for half-maximal twitch tension, but maximal
Table 1. EDL muscle core pO2 in tissue baths sparged with O2
O2, % Muscle pO2, mmHg
1 3.5  2.4
20 40.7  6.5
95 387  19.1
Measured with an oxygen electrode. Results are mean  SE; n  4.
Fig. 1. Isometric twitch tension evoked by maximal or approximately half-
maximal single-twitch stimulation of EDL from WT (A) or nNOS/ (B) mice, at
1% or 20% O2, and in the presence or absence of the NOS inhibitor, L-NAME.
Histograms illustrate force production normalized for EDL cross-sectional area
(Mcm2). Each bar represents measurements obtained from 8–10 individual
EDL muscles. (A) For submaximal stimulation, significance was attained (P 
0.05) by the increase in twitch force at 1% vs. 20% O2 in the absence of L-NAME
(*), by the decrease in twitch force at 1% O2 in the presence vs. absence of
L-NAME (**) and by the increase in twitch force at 20% O2 in the presence vs.
absence of L-NAME (***). At maximal twitch tension, the L-NAME-induced
decrease in twitch force at 1% O2 was significant. (B) Twitch force was
independent of pO2 in EDL from nNOS/ mice. Note that maximal twitch
force was significantly greater in nNOS/ EDL (B) vs. WT EDL (A) at both 1%
and 20% O2 and that this increase was also significant for submaximal twitch
force at 20% O2 (P  0.05).
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twitch force was increased by 22%, and at 20% O2, twitch force
increased by 54% for both submaximal and maximal twitch
tensions (P  0.05). These observations indicate the operation
of distinct NO-independent compensatory force-enhancing
mechanisms that are regulated by O2 in fast-twitch muscle
deprived chronically of nNOS activity.
The effects on twitch tension of acute NOS inhibition pro-
vided additional evidence for concerted regulation by NO and
O2 of EDL function (Fig. 1 A). At a physiological O2 concen-
tration of 1% O2 (characteristic of active muscle), L-NAME
treatment (1 mM) reduced half-maximal and maximal twitch
force by 30% and 42%, respectively (P  0.05), which is closely
comparable to the difference between twitch tensions obtained
at 1% and 20% O2. Thus, consistent with the results from EDL
of nNOS/ mice, the magnitude of the NO-dependent enhance-
ment of contractility revealed by L-NAME accounts fully for the
potentiating effects on twitch tension of low vs. high pO2. In
striking contrast, but consistent with previous observations (5, 6,
16), twitch force was enhanced by L-NAME at 20% O2, resulting
in increases of 43% and 24% for submaximal and maximal twitch
tensions, respectively (P  0.05; Fig. 1 A). The enhancement of
force production by NOS inhibition in the ambient air condition
(40 mmHg) indicates that at higher physiological pO2 (asso-
ciated with relative muscle inactivity), NO exerts an inhibitory
influence on the contractile apparatus. The mechanism of action
is unlikely to involve a direct modulation of Ca2 release from
the SR because RyR1 is not modified by NO at supranormal pO2
(10, 15).
We also examined the response of EDL to trains of stimuli that
produce tetanic (fused) contractions, and, which, relative to
single-twitch stimulation, will evoke large and sustained in-
creases in cytosolic Ca2 levels and NO production (6). We used
pulse trains comprised of individual pulses with amplitudes
corresponding to either half-maximal or maximal single-twitch
stimulation, and in no case did stimulus amplitude influence the
reported effects of pO2 or of NO. In addition, it should be noted
that, although maximal tetanic tension developed at stimulus
rates of 200–250 per sec under all conditions (Figs. 2 and 3),
observations in intact, behaving rodents indicate that the phys-
iological range of sustained discharge of motor neurons supply-
ing fast-twitch muscles of the limb extends only through 100
per sec (17, 18), which in fact encompasses the range over which
we observed the largest NOO2-dependent differences in con-
tractility (vide infra).
Normalized force frequency curves obtained from WT EDL
at 1% vs. 20% O2 did not differ significantly over the measured
tetanic frequency range of 40–250 Hz. (Fig. 3A). However,
consistent with the pO2-dependent effects of acute NOS inhi-
bition on twitch tension (Fig. 1 A), treatment with L-NAME
resulted in a leftward shift of the force frequency relationship at
20% O2 and a rightward shift at 1% O2 (Fig. 3A). The difference
between the normalized force frequency curves at 1% O2 and
20% O2 after L-NAME treatment was significant over the
physiologically relevant range of 40–120 Hz (P  0.05). More
strikingly, plots of absolute force vs. stimulation frequency
revealed that acute NOS inhibition produced substantial in-
creases in tetanic force at 20% O2 (Fig. 3B), which averaged 68%
and were significant over the frequency range of 40–120 Hz vs.
both 20% O2 in the absence of L-NAME (P  0.05; Fig. 3B) and
1% O2 in the presence or absence of L-NAME (P  0.05; Fig.
3B). Force generationstimulation frequency curves obtained at
20% O2 in the absence of L-NAME were not significantly
different from 1% O2 in the presence of L-NAME and 1% O2 in
the absence of L-NAME (Fig. 3B). Tetanic force generation by
WT EDL at 95% O2 was substantially greater than at 1% O2 or
20% O2 (with peak tensions of 35–40 Mcm2, which is
equivalent to 20 g; Figs. 2 A and 3 B and C), but, whereas
L-NAME treatment yielded a small but significant leftward shift
in the normalized force frequency curves at lower stimulus
frequencies (consistent with previous findings at 95% O2; refs.
5, 6, and 12), no significant differences were obtained between
absolute force vs. frequency curves at 95% O2 in the presence vs.
absence of L-NAME (Fig. 3 C and D). Thus, the inhibitory
influence of NO on force production evident at 20% O2 (40
mmHg) is no longer exerted in the extreme redox environment
created 95% O2 (400 mmHg). Taken together, the effects of
NOS inhibition on contractile responses to repetitive stimulation
indicate that the influence of NO varies with pO2 and muscle
activation, which will conjointly determine the redox milieu of
critical subcellular compartments (19, 20).
Normalized force-frequency curves from EDL of nNOS/
mice were essentially indistinguishable at 1%, 20%, and 95% O2
(Fig. 3 E and H). Thus, in the chronic absence of nNOS-derived
NO, pO2 exerts no influence on the form of the force-frequency
relationship obtained by repetitive stimulation. In addition,
L-NAME had no significant effect on either normalized or
absolute force frequency curves from nNOS/ mice (Fig. 3 G
and H). However, consistent with the increase in twitch force
generated by EDL of nNOS/ vs. WT (Fig. 1B), tetanic force
production by EDL of nNOS/ mice at 20% O2 (Figs. 2B and
3F) was greater than at 1% O2 and exceeded force generation by
WT EDL at 1% or 20% O2 (P  0.05; tetanic force production
Fig. 2. Reversibility and NOO2 regulation of twitch and tetanic force
production by the left and right EDLs from an individual WT and an individual
nNOS/ mouse. (A) Strain gauge recordings from a pair of simultaneously
assayed WT EDLs illustrate the rapid and bidirectional changes in tetanic
twitch tension after switching between 20% and 95% O2 [maximum force at
95% O2 (left EDL)  36 Mcm2]. (B) Records from a pair of simultaneously
assayed nNOS/ EDLs illustrate that neither half-maximal nor maximal twitch
tension differs at 1% vs. 20% O2, whereas tetanic force generation is substan-
tially greater at 20% O2 than at 1% O2 (see also Figs. 1B and 3D).







did not differ significantly between nNOS/ EDL at 1% O2, WT
EDL at 1% O2, and WT EDL at 20% O2). Thus, pO2-dependent
differences in force generation were revealed in the absence of
nNOS as well as by acute NOS inhibition (Fig. 3 A and B).
Furthermore, the pO2-dependent difference in force generation
by EDL from nNOS/ mice increased with increasing tetanic
stimulus frequency (Figs. 2B and 3F). As for WT EDL, force
generation by nNOS/ EDL was greater at 95% O2 than at 1%
O2 and at 20% O2 (Fig. 3 F and G). It should be noted that at
95% O2, force production by nNOS/ EDL and WT EDL was
similar (Fig. 3 C and G), i.e., the enhanced contractility of
nNOS/ EDL at low and intermediate pO2 is much less evident
at grossly supranormal oxygen tension. These observations
establish that tetanic force generation is increased in nNOS/
muscle at higher physiological pO2 and suggest that mechanisms
operating to increase force production may include increased
generation of or sensitivity to force-enhancing factors, such as
reactive oxygen species (ROS, which may be produced in greater
quantities with increasing pO2 and muscle activation), and that
pathological amounts of ROS may obscure redox signaling (19,
20). We have observed only minimal effects of CuZn super-
oxide dismutase, applied to intact muscle (19), on force pro-
duction by EDL (unpublished results), but a role for ROS
generated and acting intracellularly remains to be examined.
A direct demonstration of concerted regulation by pO2 and
NO of both Ca2 f lux and contractile function was provided by
analysis of depolarization-induced changes in cytoplasmic Ca2
levels and sarcomere length in myocytes isolated from FDB (of
WT and nNOS/ mice and examined at 1% O2 and 20% O2 (14)
(Fig. 4). Both calcium transients and sarcomere shortening
evoked by brief electrical stimulation were significantly greater
at 1% O2 than at 20% O2 in myocytes derived from WT FDB
(P  0.05), whereas pO2 had no effect on either measure in
nNOS/ myocytes. In addition, both the amplitude of Ca2
transients and the magnitude of sarcomere shortening were
significantly greater at 20% O2, but not at 1% O2, in nNOS/
vs. WT myocytes (P  0.05). Thus, these observations confirm
at the level of single muscle cells both the facilitatory action of
NO on contractility at low physiological pO2 and the pO2-
regulated compensatory enhancement of contractile function in
nNOS/ muscle. At the molecular level, the pO2-dependent
influence of NO on Ca2 transients, which are known to reflect
primarily Ca2 release through RyR1 (21), supports a role for
RyR1 as a principal locus of action in concerted redox regulation
by pO2 and NO (10, 15).
Discussion
Our findings demonstrate that skeletal muscle contractility
varies with oxygen tension and that this pO2-dependent mod-
ulation is effected in substantial part through the action of NO
generated by nNOS in situ. Concerted regulation by NO and
O2 of E–C coupling and force production operates at both low-
and high-oxygen tension. The inf luence of NO at low physi-
ological pO2 is facilitatory, whereas NO inhibits contractility
Fig. 3. Contractile force evoked by tetanic stimulation (40–250 Hz) of EDL from WT (A–D) and nNOS/ (E–H) mice at 1%, 20%, or 95% O2, and in the presence
or absence of the NOS inhibitor, L-NAME. All significant differences (P  0.05) are indicated by asterisks. (A) Normalized force frequency curves illustrate that,
in WT mice, L-NAME induces a leftward (facilitatory) shift at 20% O2 and a rightward (inhibitory) shift at 1% O2. Significant differences were obtained between
the curves at 1% and 20% O2 in the presence of L-NAME over the stimulation range of 40–120 Hz (SE indicated only for measurements in the presence of L-NAME).
(B) Plots of force generation vs. stimulation frequency illustrate that force production is enhanced significantly at 20% O2 in the presence vs. absence of L-NAME
over the stimulation range of 40–120 Hz. There were no significant differences between force generationstimulation-frequency curves obtained at 20% O2 in
the absence of L-NAME, 1% O2 in the absence of L-NAME, and 1% O2 in the presence of L-NAME, and, for clarity, the averaged curve for 1% O2 in the absence
and presence of L-NAME is shown in red. (C) At 95% O2, L-NAME treatment has no significant effect on force generated by tetanic pulse trains but results in a
leftward (facilitatory) shift in normalized frequency force curves at 70–120 Hz (D). (E–H) EDL from nNOS/ mice. Normalized force frequency curves are
essentially indistinguishable at 1% vs. 20% O2 (E), but force generation is enhanced significantly at 20% vs. 1% O2 over the stimulation range of 70–250 Hz (F).
L-NAME has no significant effect on nNOS/ EDL contractility, as illustrated with results obtained at 95% O2 (G and H). Note that, as for WT EDL, force generation
by nNOS/ EDL is greater at 95% O2 than at 20% or 1% O2, but that force production by WT EDL and nNOS/ EDL is comparable at 95% O2.
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at higher physiological pO2. Only the inhibitory inf luence has
been described in previous studies (6) of mammalian striated
muscle, which have been conducted exclusively at entirely
nonphysiological oxygen tension (95% O2). Furthermore, be-
cause those results (obtained with pharmacological inhibitors)
were not consistent with the reported absence of altered
muscle function in nNOS/ or nNOS-deficient mdx mice (2,
3, 22), the importance of NO in E–C coupling and its potential
pathophysiological significance in dystrophic disease have
remained in question.
The facilitatory action of NO at normal muscle pO2 supports
the physiological importance of NO-dependent enhancement
of calcium release from skeletal muscle SR through S-
nitrosylation of RyR1 at physiological but not supranormal
pO2, observed in vitro (10). In addition, it has recently been
shown that endogenous NO enhances RyR-mediated release
of Ca2 from SR of cardiac myocytes (23), an action mediated
specifically by nNOS (14). The inhibitory effects of NO on
contractility at higher pO2 may ref lect the operation of distinct
molecular mechanisms, which are revealed most prominently
under conditions of oxidative stress. Redox-sensitive muscle
proteins that are reported to be modified by NO or S-
nitrosoglutathione (GSNO) include the Ca2-dependent
ATPase of the SR (24, 25), which regulates SR-cytosol Ca2
homeostasis, and constituents of the myofilaments (26, 27),
which directly subserve contractile function. In addition, ac-
tivation of guanylate cyclase has been implicated in depression
of muscle force by NOGSNO in previous studies (5, 28)
conducted at supraphysiological pO2.
Regardless of the identity of the full spectrum of proteins
acted on by NOnitrosylation in muscle cells, our experimental
results support a model under which the targets, mechanisms of
action, and functional effects of endogenous NO will vary
continuously with muscle redox status, linked to oxygen tension
(and presumably ROS production). The contingent effects of
NO would thus couple modulation of contractility to ongoing
muscle activity and metabolic demand. Low pO2 in working
muscle would increase contractility and rises in pO2 in resting
muscle would attenuate contractility, which is analogous to the
pO2-dependent regulation of red blood cell-derived NO vaso-
activity that couples peripheral blood flow to local metabolic
demand (i.e., hypoxic vasodilation and hyperoxic vasoconstric-
tion; refs. 29 and 30). Accordingly, O2-regulated, NOS-
nitrosothiol-based signals would coordinately regulate both
blood flow and contractility in striated muscle beds. This model
may apply more generally across cell types and subcellular
compartments in which NO-derived bioactivity is exerted, and
may thus provide a framework for elucidating the role of NO in
redox-based regulation of protein function and cellular physiol-
ogy (1), which has been largely masked in studies performed to
date at supraphysiological pO2.
Increased force production as a result of oxidative insult (see
95% O2 in Figs. 2 and 3) or NOS deficiency (Figs. 1, 2, and 3 F
and G) may provide a compensatory mechanism to maintain
performance by injured or diseased (dystrophic) muscle. Indeed,
it may be the case that chronic deprivation of NO results in
oxidative stress. However, this greater force production comes at
a price: NO and O2 no longer exert coordinate control (RyR
activity is not regulated by S-nitrosylation at supraphysiological
pO2). This broader perspective may provide a novel molecular
basis for diverse myopathies that are associated with altered
expression, distribution or activity of NOS, andor impairment
of oxygenation or blood flow, previously subsumed under the
rubric of oxidativenitrosative stress, but here viewed as symp-
tomatic of an imbalance in NOO2-based signaling that is
essential for normal calcium-regulated muscle function. That is,
rather than viewing oxidativenitrosative stress simply in terms
of oxidative injury to muscle, our results suggest that impair-
ments in muscle performance may result from physiological
alterations in NOO2 balance that disrupt nitrosylationredox-
based signaling.
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